Key result
Modern cardiac troponin assays correlate poorly, yielding up to ~70% unique elevations per assay.
Why the study?
Do different modern cardiac troponin assays identify the same healthy individuals as being above the 99th percentile cutoff?
Cross-Sectional (n=2,005)
Do different modern cardiac troponin assays identify the same healthy individuals as being above the 99th percentile cutoff?
There is poor concordance among different high-sensitivity cardiac troponin assays at the 99th percentile cutoff, suggesting that delta values should be emphasized over absolute cutoffs for diagnosing myocardial infarction.
Answers are grounded in this paper and cite their sources.
Discordant troponin results above the 99th percentile across assays may complicate single-value interpretation; leaves open assay-specific thresholds or delta-based strategies.
BACKGROUND: We compared the 99th percentile reference intervals with 3 modern cardiac troponin assays in a single cohort and tested the hypothesis that the same individuals will be identified as above the cutoff and that differences will be explained by analytical imprecision. METHODS: Blood was collected from 2005 apparently healthy blood donors. Cardiac troponin was measured with Abbott Architect STAT high sensitive troponin I, Beckman Coulter Access AccuTnI+3, and Roche Elecsys troponin T highly sensitive assays. RESULTS: The 99th percentile cutoff limits were as follows: Abbott cardiac troponin I (cTnI) 28.9 ng/L; Beckman Coulter cTnI 31.3 ng/L; and Roche cardiac troponin T (cTnT) 15.9 ng/L. Correlation among the assays was poor: Abbott cTnI vs Beckman Coulter cTnI, R(2) = 0.18; Abbott cTnI vs Roche cTnT, R(2) = 0.04; and Beckman Coulter cTnI vs Roche cTnT R(2) = 0.01. Of the results above the cutoff 50% to 70% were unique to individual assays, with only 4 out of 20 individuals above the cutoff for all 3 assays. The observed differences among assays were larger than predicted from analytical imprecision. CONCLUSIONS: The 99th percentile cutoff values were in agreement with those reported elsewhere. The poor correlation and concordance amongst the assays were notable. The differences found could not be explained by analytical imprecision and indicate the presence of inaccuracy (bias) that is unique to sample and assay combinations. Based on these findings we recommend less emphasis on the cutoff value and greater emphasis on δ values in the diagnosis of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Ungerer et al. (2016) conducted a cross-sectional in Healthy blood donors (n=2,005). Cardiac troponin assays (Abbott hs-cTnI, Beckman Coulter cTnI, Roche hs-cTnT) was evaluated on 99th percentile reference intervals and assay correlation. Three modern cardiac troponin assays demonstrated poor correlation, with 50% to 70% of results above the 99th percentile cutoff being unique to individual assays.
Synapse has enriched 10 related papers. Consider them for comparative context: